Aquis Exchange listed Truspine Technologies #TSP is both owner and developer of three uniquely disruptive technologies to revolutionise the spinal stabilisation market. These pioneering spinal devices, namely Cervi-LOK™ (for the cervical and upper thoracic spine), GRASP Laminoplasty (a treatment for decompression of the spinal cord) & Faci-LOK™ (for the lumbar and lower thoracic spine) are at various stages of development. Alan Green is joined today by newly appointed CEO Laurence Strauss to discuss his appointment and the upcoming GM on May 31st called by certain shareholders petitioning to remove the board and turn the company into a cash shell. Laurence explains the Board position, how he believes the ‘greedy requisitioners’ wish to steal the IP from the company. A lawyers letter is shown, ostensibly irrefutable proof that Truspine owns the IP. Laurence then looks at the financial position and the planned refinancing after the GM has taken place.